Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease
Michael R. Jones(University of Calgary), Tim Storr(Simon Fraser University), Mi Hee Lim(Korea Advanced Institute of Science and Technology), Shigeki Tsutsui(Allen Institute for Brain Science), Kyle J. Korshavn(University of Michigan), Émilie Mathieu(Simon Fraser University), Peter K. Stys(Allen Institute for Brain Science), Christine Dyrager(Uppsala University), V. Wee Yong(University of Calgary), Simon Faissner(St. Josef-Hospital), Zavier Vaillancourt(Simon Fraser University), Ayyalusamy Ramamoorthy(Florida State University)
Cited by 93
Related Papers
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
|Nature Communications|2020|601
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
|Nature Reviews Drug Discovery|2019|456
Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis
|Journal of Clinical Investigation|2019|137
Metal complexes that bind to the amyloid-β peptide of relevance to Alzheimer’s disease
|Coordination Chemistry Reviews|2020|89